Skip to content

PEPENDIUM LABS

Free research / Saved source records

Saved studies for Tirzepatide

This collection contains studies found in earlier source checks. Historical collection checks Europe PMC and ClinicalTrials.gov; live search also checks PubMed when available. The collection can include older work beyond live search windows, but is not a complete archive. Source metadata may have changed since the last check. See collection progress.

Historical scan for Tirzepatide

4 year/page windows checked · Last completed: Tue, 29 Sep 2026 11:31:29 GMT · Next: 2026, page 5.

This progress applies to the tracked spelling shown above. It does not measure every study or every source.

52 saved studies linked to this search · Page 1

Original study · Category hint: Other or unclear · Published: 2026-09-21

Real-World Adverse Event Reporting Patterns of Tirzepatide Versus Semaglutide: A Stratified Study of General and Healthcare Professional Cohorts in FAERS.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-09-21

Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-20

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-19

Changes in Abdominal Adiposity and Associations With Metabolic Health Markers Following Tirzepatide in Japanese Participants With Obesity Disease: Results From the SURMOUNT-J Study.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-17

Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Case report · Published: 2026-09-17

Simultaneous and recurrent hordeola and chalazia associated with tirzepatide therapy: a case series.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-14

Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-11

Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-09-11

Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Animal · Published: 2026-09-10

Increased Energy Expenditure through Intermittent Cold Exposure Does Not Enhance Tirzepatide Induced Weight-loss in Obese Mice.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-09-10

Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-09-08

Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-09-08

Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-09-03

Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Case report · Published: 2026-09-03

Tirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Animal · Published: 2026-09-02

Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Case report · Published: 2026-09-01

Case report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Case report · Published: 2026-08-31

Tirzepatide non-response with subsequent semaglutide response in class 2 obesity.

Last found in a complete check: Sep 29, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-08-20

Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-08-06

Real-World Effectiveness and Treatment Patterns of Tirzepatide in a Large UK Digital Health Cohort.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Case report · Published: 2026-08-04

Confluent and reticulated papillomatosis improvement with tirzepatide-associated weight loss: A case report.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-08-04

GLP-1 Receptor Agonist Therapy for Obesity Under Japan's Optimal Use Guideline: A Prospective Real-World Study of Lifestyle Pre-Treatment, Time-Limited Treatment Cap, and Post-Cessation Regain.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-08-01

Real-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: A prospective study.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Human · Published: 2026-07-28

Low-Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non-Diabetic Japanese Adults.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Original study · Category hint: Other or unclear · Published: 2026-07-21

Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.

Last found in a complete check: Sep 28, 2026

View at Europe PMC ↗

Check live sources for Tirzepatide →